This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Journalology/ Peer Review/ Authorship  • Medical Practice  • Medical Ethics  • Neurology  • Alzheimer Disease  • Cognitive Disorders  • Statistics and Research Methods  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The Editorial on integrity in medical science by Drs DeAngelis and Fontanarosa¹ focused on US authorship practices, primarily industry-funded research articles, but its ideas merit broader consideration. Lack of integrity probably exists in all countries and all research types, and scientists should be more aware of good authorship practice. However, few data about this exist.

My colleagues and I conducted 39 semidirective interviews of clinical investigators (mean [SD] age, 52 [8] years) who had published data on French public-funded research programs.² Confidentiality was guaranteed and we believe that interviews were therefore conducted with openness. We found that 33 investigators (84%) were unable to cite even 1 of the 3 International Committee of Medical Journal Editors (ICMJE) authorship criteria, 23 (59%) acknowledged having been recipients of guest authorship, and only 7 (18%) agreed that the 3 criteria must be met.

In this environment, authorship may often be the . . . [Full Text of this Article]

Hervé Maisonneuve, MD
hervemaisonneuve@gmail.com
"Santé Individu Société" Research Unit
Université Claude Bernard
Lyon, France

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence
and
JAMA. ;299():1833-1835.
FULL TEXT  

RELATED LETTERS

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():900-900.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():900-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():901-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():901-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
, , and
JAMA. ;300():901-902.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():902-902.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():902-903.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():903-904.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():904-904.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
and
JAMA. ;300():904-904.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
, , and
JAMA. ;300():904-905.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
and
JAMA. ;300():905-906.
FULL TEXT